At the news
? BEARISHIMPACT 7/10 S-3 filed Mar 2, 2026 at 16:17 ET
Rocket Pharmaceuticals has filed a shelf registration (S-3) for up to $400 million in securities, including common stock, preferred stock, debt, warrants, or units. This filing signals potential future dilutive capital raises but does not specify immediate issuance. The company is a small-cap biotech with a market cap of $3 million, recently restructuring to extend its cash runway.
- Rocket Pharmaceuticals filed an S-3 shelf registration for up to $400,000,000 in securities (common stock, preferred stock, debt, warrants, or units)
- Market cap is only $3 million, meaning the offering could represent over 13,000% of current market value if fully utilized
- No specific offering details provided - this is a registration for potential future issuances
- Company recently implemented a 30% workforce reduction and cut operating expenses by 25% to extend cash runway
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access